PRESS RELEASE published on 02/06/2025 at 19:30, 1 year 3 months ago Informations privilégiées / Autres communiqués La BEI lève deux clauses financières du contrat de prêt avec Medincell. 40 millions d'euros accordés en 2022 remplacent un prêt de 20 millions. Tranches A, B, C tirées en 2022-2023, première maturité en 2027. Deux clauses financières seront levées Medincell Maturité BEI Prêt Clauses Financières
BRIEF published on 01/29/2025 at 15:47, 1 year 3 months ago UZEDY® Achieves $117M in Sales in 2024 Teva Pharmaceuticals 2025 Projections UZEDY® Sales Medincell Partnership Olanzapine Injectable
BRIEF published on 01/29/2025 at 15:47, 1 year 3 months ago UZEDY® réalise un chiffre d'affaires de 117 millions de dollars en 2024 Teva Pharmaceuticals Prévisions Pour 2025 Olanzapine Injectable Ventes UZEDY® Partenariat Medincell
PRESS RELEASE published on 01/29/2025 at 15:42, 1 year 3 months ago Inside Information / Other news releases UZEDY® sales reach $117M in 2024, surpassing Teva's expectations. Medincell poised for $160M in 2025 with Olanzapine Long-Acting Injectable near launch. Key partnership and financial insights Sales Partnership Medincell Teva Pharmaceuticals UZEDY®
PRESS RELEASE published on 01/29/2025 at 15:42, 1 year 3 months ago Informations privilégiées / Autres communiqués Les ventes de UZEDY® par Teva Pharmaceuticals atteignent 117 M$ en 2024, dépassant les prévisions, Medincell perçoit des royalties. Préparation de lancement de l'Olanzapine LAI (TEV-749 / mdc-TJK) Royalties Medincell Teva Pharmaceuticals Olanzapine LAI UZEDY®
BRIEF published on 12/12/2024 at 21:35, 1 year 5 months ago Medincell Joins Euronext SBF 120 Index Market Capitalization Medincell CAC 40 Euronext SBF 120 Financial Visibility
BRIEF published on 12/12/2024 at 21:35, 1 year 5 months ago Medincell rejoint l'indice Euronext SBF 120 Capitalisation Boursière Visibilité Financière CAC 40 Euronext SBF 120 Médinecell
PRESS RELEASE published on 12/12/2024 at 21:30, 1 year 5 months ago Inside Information / Other news releases Medincell joins Euronext SBF 120 & CAC Mid 60 indices, enhancing visibility and investor appeal. Market capitalization-based indices by Euronext. Effective inclusion from Dec 20 Market Capitalization Medincell Index Inclusion Euronext SBF 120 CAC Mid 60
PRESS RELEASE published on 12/12/2024 at 21:30, 1 year 5 months ago Informations privilégiées / Autres communiqués Medincell intègre l'indice Euronext SBF 120 et CAC Mid 60, renforçant sa visibilité et attractivité pour les investisseurs. Découvrez les déclarations et impacts de cette intégration Euronext Intégration SBF 120 Medincell CAC Mid 60
PRESS RELEASE published on 12/10/2024 at 17:47, 1 year 5 months ago Medincell Rapport Financier semestriel 01-04-24 au 30-09-2024
Published on 05/13/2026 at 00:00, 1 hour 8 minutes ago Onco-Innovations Announces Initiation of Research Collaboration within PROmAI
Published on 05/12/2026 at 23:35, 1 hour 33 minutes ago Infield Minerals Closes $1.25 Million Financing
Published on 05/12/2026 at 21:55, 3 hours 13 minutes ago UraniumX Discovery Corp Announces Option Agreement with Gold'n Futures
Published on 05/12/2026 at 21:42, 3 hours 26 minutes ago Kidoz Inc. to Present at Planet MicroCap Las Vegas 2026
Published on 05/12/2026 at 14:30, 10 hours 38 minutes ago Pathfinder Ventures Inc. Announces Conclusion of Financing and Intention to Launch New Private Placement
Published on 05/12/2026 at 23:47, 1 hour 20 minutes ago Nebius welcomes Clarifai’s core team and licenses inference IP to strengthen Nebius Token Factory
Published on 05/12/2026 at 22:25, 2 hours 42 minutes ago Evotec SE Successfully Placed €116.1 Million Convertible Bonds
Published on 05/12/2026 at 20:21, 4 hours 46 minutes ago Nebius breaks ground on gigawatt-scale AI factory in Independence, Missouri
Published on 05/12/2026 at 19:35, 5 hours 33 minutes ago AUSTRIACARD HOLDINGS AG: Q1 2026 Financial Results
Published on 05/12/2026 at 19:35, 5 hours 33 minutes ago 2026 Annual General Meeting: Strong vote by shareholders in favour of continuity in leadership and strategy
Published on 05/12/2026 at 18:15, 6 hours 53 minutes ago AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 30/04/2026
Published on 05/12/2026 at 18:15, 6 hours 53 minutes ago AXA: Information relating to the number of voting rights and shares making up the share capital on 30/04/2026
Published on 05/12/2026 at 18:10, 6 hours 58 minutes ago imerys-12-05-2026-communiqué-compte-rendu-de-l-assemblée-générale-ordinaire-du-12-mai-2026
Published on 05/12/2026 at 18:10, 6 hours 58 minutes ago imerys-12-05-2026-press-release-summary-of-the-ordinary-shareholders-general-meeting-12-may-2026
Published on 05/12/2026 at 17:50, 7 hours 18 minutes ago Damartex fait évoluer sa gouvernance et engage une réflexion stratégique autour de ses activités
